Published in Women's Health Weekly, August 19th, 2004
Sanctura was recently approved by the U.S. Food and Drug Administration (FDA) and is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly